| Execution period | April 15, 2026 to April 29, 2026 |
|---|
NSE filing, NSE: SEPC. Summary written from the filing by ALFA Finder's alert engine.
SEPC Ltd: key numbers
- Share price
- ₹4.80
- Market cap
- ₹919.5 Cr
- Revenue (annual)
- ₹1,054 Cr
- Net profit (annual)
- ₹53.54 Cr
- P/E (TTM)
- 35.5×Sector 32.2×
- Promoter holding
- 9.39%-2.28% QoQ
- FII holding
- 0.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SEPC Ltd
All →SEPC Legal & Regulatory
SEPC Ltd reports a Jharkhand High Court interim stay on government rescission notices for seven rural water supply contracts, with next hearing on 30 November 2026. The stay protects contractual rights but the dispute is ongoing.
SEPC Adverse Business Impact
SEPC received letters rescinding seven Jharkhand water supply contracts from DDWS. The company is pursuing remedies, including dispute resolution and arbitration.
- From
- Department of Drinking Water and Sanitation, Government of Jharkhand
SEPC Preferential Issue
SEPC confirmed its valuation report (₹10/share) for a non-cash preferential issue remains unchanged. A detailed report with calculations was submitted for stakeholder transparency.
SEPC Other Announcement
SEPC Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing discloses the stake distribution among various shareholder categories.
SEPC Bags ₹854.6 Cr Order from SAIL-IISCO Steel Plant
SEPC signed a ₹854.57 Crore contract with SAIL-IISCO for Pellet Plant BOP works at Burnpur. Consolidated order book now crosses ₹10,000 Crore.
- Value
- ₹854.6 Cr
- From
- SAIL-IISCO Steel Plant (Steel Authority of India Limited)
- Execution
- 32 months from September 3, 2026
- Order book
- ₹10,000 Cr
SEPC Legal & Regulatory
The Madras High Court has lifted the attachment on ₹154 crore of SEPC's receivables following a dispute settlement, with no monetary outflow for the company.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr